0

GSK2033

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP1221277902
CAS1221277-90-2
MDL NumberMFCD28396416
Molecular Weight591.66
InChI KeyPSOXOVKYGWBTPB-UHFFFAOYSA-N
Description≥98% (HPLC)
SolubilityDMSO: 3 mg/mL, clear (warmed)
Assay≥98% (HPLC)
Colorwhite to beige
Formpowder
Size5MG, 25MG
Storage Conditions2-8°C
1

Activation of Liver X Receptor Promotes Hippocampal Neurogenesis and Improves Long-Term Cognitive Function Recovery in Acute Cerebral Ischemia-Reperfusion Mice

Lili Chen, Dan Song, Beibei Chen, Xuemei Yang, Oumei Cheng

J Neurochem. 2019 Oct 10.

PMID: 31602646

1

Anti-atherosclerotic Effects of LXRα Agonist Through Induced Conversion of M1 Macrophage to M2

Fangfang Dou, Jiulin Chen, Hui Cao, Qingling Jia, Dingzhu Shen, Te Liu, Chuan Chen

Am J Transl Res. 2019 Jun 15;11(6):3825-3840.

PMID: 31312392

1

Discovery of Tertiary Sulfonamides as Potent Liver X Receptor Antagonists

William J Zuercher, Richard G Buckholz, Nino Campobasso, Jon L Collins, Cristin M Galardi, Robert T Gampe, Stephen M Hyatt, Susan L Merrihew, John T Moore, Jeffrey A Oplinger, Paul R Reid, Paul K Spearing, etc.

J Med Chem. 2010 Apr 22;53(8):3412-6.

PMID: 20345102

1

Promiscuous Activity of the LXR Antagonist GSK2033 in a Mouse Model of Fatty Liver Disease

Kristine Griffett, Thomas P Burris

Biochem Biophys Res Commun. 2016 Oct 21;479(3):424-428.

PMID: 27680310

1

Separating the Anti-Inflammatory and Diabetogenic Effects of Glucocorticoids Through LXRβ Antagonism

Rucha Patel, Lilia Magomedova, Ricky Tsai, Stéphane Angers, Arturo Orellana, Carolyn L Cummins

Endocrinology. 2017 Apr 1;158(4):1034-1047.

PMID: 28324010

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode